Related references
Note: Only part of the references are listed.Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
Rita G. Ladstein et al.
BMC CANCER (2010)
AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
D. Mark Hickinson et al.
CLINICAL CANCER RESEARCH (2010)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Monitoring Tumor Response to Therapy with F-18-FLT PET
Wolfgang A. Weber
JOURNAL OF NUCLEAR MEDICINE (2010)
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
Esther G. C. Troost et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
Chirayu Shah et al.
CLINICAL CANCER RESEARCH (2009)
Using Dual-Tracer PET to Predict the Biologic Behavior of Human Colorectal Cancer
Wang Hui et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
18F-FDG and 18F-FLT Uptake Early After Cyclophosphamide and mTOR Inhibition in an Experimental Lymphoma Model
Lieselot Brepoels et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards
Qinan Bao et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Assessing Tumor Response to Therapy
Wolfgang A. Weber
JOURNAL OF NUCLEAR MEDICINE (2009)
Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone
T. Ebenhan et al.
MOLECULAR IMAGING AND BIOLOGY (2009)
The effect of PPAR-γ agonist on 18F-FDG uptake in tumor and macrophages and tumor cells
Se-Lim Kim et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II
Kenichiro Hamada et al.
ANNALS OF NUCLEAR MEDICINE (2008)
[18F] Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
Hee-Jung Sohn et al.
CLINICAL CANCER RESEARCH (2008)
Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib
Ajit Shinto et al.
CLINICAL NUCLEAR MEDICINE (2008)
Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922
Mats Bergstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Imaging of cell proliferation: Status and prospects
James R. Bading et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT
Andreas K. Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Imaging early changes in proliferation at 1 week post chemotherapy:: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
Laura Kenny et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts
Neil R. Smith et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Biological correlates of FDG uptake in non-small cell lung cancer
Lioe-Fee de Geus-Oei et al.
LUNG CANCER (2007)
2-Deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines
A. M. Lutz et al.
MOLECULAR IMAGING AND BIOLOGY (2007)
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer
Jinyu Gu et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Molecular Imaging of proliferation in malignant lymphoma
Andreas K. Buck et al.
CANCER RESEARCH (2006)
Quantifying the activity of adenoviral E1A CR2 deletion mutants using Renilla luciferase bioluminescence and 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography imaging.
Julius Leyton et al.
CANCER RESEARCH (2006)
GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1
Qingwen Jin et al.
VIROLOGY (2006)
Current concepts - Positron-emission tomography and assessment of cancer therapy
ME Juweid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Usefulness of 3 '-[F-18]fluoro-3 '-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy
BS Pio et al.
MOLECULAR IMAGING AND BIOLOGY (2006)
A pilot evaluation of the use of tissue microarrays for quantitation of target distribution in drug discovery pathology
JS McKay et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2006)
Simplified, automated synthesis of 3'[F-18]fluoro-3'-deoxy-thymidine([F-18]FLT) and simple method for a metabolite analysis in plasma
G. Reischl et al.
RADIOCHIMICA ACTA (2006)
Comparison of [F-18]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer
JK Chung et al.
NUCLEAR MEDICINE COMMUNICATIONS (2004)
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis
JF Eary et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Share Paper
